Mark Durham

Overview

Mark Durham received an average of $1M in total compensation, including $343K in salary, at Valeant Pharmaceuticals International from 2008 to 2011.

Source: SEC filings on April 30, 2012 and April 14, 2011.

Related executives

We found 27 more executives who work or worked at Valeant Pharmaceuticals International.

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

Thomas Appio

Valeant Pharmaceuticals International

President Co, Head Bausch + Lomb/International

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

Sam Eldessouky

Valeant Pharmaceuticals International

Chief Financial Officer

Robert Spurr

Valeant Pharmaceuticals International

President, U.S. Pharma Business

Joseph Gordon

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

William Humphries

Valeant Pharmaceuticals International

Group Chairman

You may also like